---
title: "MILLER MICHAEL PATRICK — Ownership Dossier"
canonical: https://whiteintel.dev/entity/fa872882-e57c-57d8-a36e-db94dc7b5bdf
json: https://whiteintel.dev/api/public/dossier/fa872882-e57c-57d8-a36e-db94dc7b5bdf
identifier: sec:0001236514
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MILLER MICHAEL PATRICK

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001236514`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/fa872882-e57c-57d8-a36e-db94dc7b5bdf  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/fa872882-e57c-57d8-a36e-db94dc7b5bdf  

## Ownership & control

### Holdings / subsidiaries

- **PUMA BIOTECHNOLOGY, INC.** (director) — https://whiteintel.dev/entity/d7626fb5-42f1-536c-bbb7-b3d646e6ae34
- **RIGEL PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/d86958a6-7ca3-521c-887c-e574ee5ee40b
- **BioXcel Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/4d4ce477-16ed-5409-88a2-aa48a5c7bb5d
- **Jazz Pharmaceuticals plc** (officer) — https://whiteintel.dev/entity/93c43bdd-29a5-5302-94c3-e122c135c53f
- **VIVUS INC** (officer) — https://whiteintel.dev/entity/bf33f93a-3f04-5162-8cf9-1812ec4d1cf7

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MILLER MICHAEL PATRICK**. Human view: https://whiteintel.dev/entity/fa872882-e57c-57d8-a36e-db94dc7b5bdf · Structured JSON: https://whiteintel.dev/api/public/dossier/fa872882-e57c-57d8-a36e-db94dc7b5bdf._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._